Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 liquidated — weigh against the wins.
1 vehicle on file, newest listing first
Bijan Salehizadeh, Senator Joseph Robert “Bob” Kerrey and Dr. Fred Moll to join our board of directors at the closing of this offering. 3 Mr. Peter Hébert is a co-founder and managing partner of Lux and oversees Lux’s investments at the intersection of technology and medical devices, including Auris Health, which was acquired by Johnson & Johnson, and Avail Medsystems. Mr. Josh DeFonzo is a former President at Johnson & Johnson (Robotics & Digital Solutions), the former Chief Operating Officer of Auris Health, and a former Chief Commercial Officer of CareDx (NASDAQ: CDNA). Ms. Segolene Scarborough is the Chief Financial Officer at Lux Capital, a former controller at Sequoia Capital, and a former senior manager at Pricewaterhouse Coopers. Dr. Bijan Salehizadeh is an experienced investor in medical technology and the co-founder and managing director of healthcare private equity firm NaviMed Capital.
This record is keyed to SEC CIK 0001552056 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 39 institutional-holder rows on these vehicles, under 22 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.